As RWD and RWE continue to rise in popularity and adoptability, it’s important to understand the benefits and applicability to stakeholders.

Our Clinical Research experts have worked collaboratively in complex studies of rare/orphan diseases with multi-specialty teams and multiple stakeholders. Offerings to our clients include customized clinical trials, epidemiology, health and policy research, and patient registry services.

Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Flora Sandra Siami, MPH, Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore.

Since its founding, our clinical research team has been deeply involved in the long-standing effort to improve these figures by conducting, or collaborating on, research in children and infants.

Research data can come in all degrees of “cleanliness.” Clean data are free of errors, out-of-range values, missing values, or misplaced values. It turns out that much can be done to improve the “cleanliness” of data — and our Resource Operations team is at the forefront of such efforts.